These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34524477)

  • 1. [Benefit assessment of digital health applications-challenges and opportunities].
    Hemkens LG
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2021 Oct; 64(10):1269-1277. PubMed ID: 34524477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ["Alternative study designs" for the evaluation of digital health applications - a real alternative?].
    Gensorowsky D; Lampe D; Hasemann L; Düvel J; Greiner W
    Z Evid Fortbild Qual Gesundhwes; 2021 Apr; 161():33-41. PubMed ID: 33642251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness of internet-based e-learning on clinician behavior and patient outcomes: a systematic review protocol.
    Sinclair P; Kable A; Levett-Jones T
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):52-64. PubMed ID: 26447007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence requirements of permanently listed digital health applications (DiGA) and their implementation in the German DiGA directory: an analysis.
    Mäder M; Timpel P; Schönfelder T; Militzer-Horstmann C; Scheibe S; Heinrich R; Häckl D
    BMC Health Serv Res; 2023 Apr; 23(1):369. PubMed ID: 37069592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relevance of different study types in benefit assessment: Results from expert interviews].
    Toews I; Bode S; Metzner G; Farin-Glattacker E; Meerpohl JJ
    Z Evid Fortbild Qual Gesundhwes; 2021 Dec; 167():25-32. PubMed ID: 34556460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical lessons learned for designing cluster randomized pragmatic clinical trials from the NIH Health Care Systems Collaboratory Biostatistics and Design Core.
    Cook AJ; Delong E; Murray DM; Vollmer WM; Heagerty PJ
    Clin Trials; 2016 Oct; 13(5):504-12. PubMed ID: 27179253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stakeholder views regarding ethical issues in the design and conduct of pragmatic trials: study protocol.
    Nicholls SG; Carroll K; Brehaut J; Weijer C; Hey SP; Goldstein CE; Zwarenstein M; Graham ID; McKenzie JE; McIntyre L; Jairath V; Campbell MK; Grimshaw JM; Fergusson DA; Taljaard M
    BMC Med Ethics; 2018 Nov; 19(1):90. PubMed ID: 30458809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit Assessment and Reimbursement of Digital Health Applications: Concepts for Setting Up a New System for Public Coverage.
    Lantzsch H; Panteli D; Martino F; Stephani V; Seißler D; Püschel C; Knöppler K; Busse R
    Front Public Health; 2022; 10():832870. PubMed ID: 35530738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digital Therapeutic Care and Decision Support Interventions for People With Low Back Pain: Systematic Review.
    Lewkowicz D; Slosarek T; Wernicke S; Winne A; Wohlbrandt AM; Bottinger E
    JMIR Rehabil Assist Technol; 2021 Nov; 8(4):e26612. PubMed ID: 34807837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing a framework for the ethical design and conduct of pragmatic trials in healthcare: a mixed methods research protocol.
    Taljaard M; Weijer C; Grimshaw JM; Ali A; Brehaut JC; Campbell MK; Carroll K; Edwards S; Eldridge S; Forrest CB; Giraudeau B; Goldstein CE; Graham ID; Hemming K; Hey SP; Horn AR; Jairath V; Klassen TP; London AJ; Marlin S; Marshall JC; McIntyre L; McKenzie JE; Nicholls SG; Alison Paprica P; Zwarenstein M; Fergusson DA
    Trials; 2018 Sep; 19(1):525. PubMed ID: 30261933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. It is important to note that RWD will never replace the more traditional and more robust RCT data; however, the emerging trend is to incorporate data that are more generalizable. Introduction.
    Mullins CD; Sanchez RJ
    J Manag Care Pharm; 2011; 17(9 Suppl A):S03-4. PubMed ID: 22074667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technology-Enabled Clinical Trials: Transforming Medical Evidence Generation.
    Marquis-Gravel G; Roe MT; Turakhia MP; Boden W; Temple R; Sharma A; Hirshberg B; Slater P; Craft N; Stockbridge N; McDowell B; Waldstreicher J; Bourla A; Bansilal S; Wong JL; Meunier C; Kassahun H; Coran P; Bataille L; Patrick-Lake B; Hirsch B; Reites J; Mehta R; Muse ED; Chandross KJ; Silverstein JC; Silcox C; Overhage JM; Califf RM; Peterson ED
    Circulation; 2019 Oct; 140(17):1426-1436. PubMed ID: 31634011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Series: Pragmatic trials and real world evidence: Paper 6. Outcome measures in the real world.
    Welsing PM; Oude Rengerink K; Collier S; Eckert L; van Smeden M; Ciaglia A; Nachbaur G; Trelle S; Taylor AJ; Egger M; Goetz I;
    J Clin Epidemiol; 2017 Oct; 90():99-107. PubMed ID: 28502810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Opportunities and Challenges of Pragmatic Randomized Trials Using a Specialized Software: CloudTrials Project.
    Fosser SM; Kamozin A; McDonald EG; Tamblyn R; Lee TC
    Stud Health Technol Inform; 2019 Aug; 264():1544-1545. PubMed ID: 31438223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving Cardiovascular Drug and Device Development and Evidence Through Patient-Centered Research and Clinical Trials: A Call to Action From the Value in Healthcare Initiative's Partnering With Regulators Learning Collaborative.
    Warner JJ; Crook HL; Whelan KM; Bleser WK; Roiland RA; Hamilton Lopez M; Saunders RS; Wang TY; Hernandez AF; McClellan MB; Califf RM; Brown N;
    Circ Cardiovasc Qual Outcomes; 2020 Jul; 13(7):e006606. PubMed ID: 32683985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.